Medications

House Dems announce sweeping investigation of drug pricing

House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political ...

Cardiology

Multiple dosing mitigates ASA hyporesponsiveness after CABG

(HealthDay)—Acetylsalicylic acid (ASA) hyporesponsiveness after coronary artery bypass graft (CABG) surgery can be overcome by multiple dosing, according to a study published online March 7 in the Journal of Thrombosis ...

Medical research

Screening enormous databases to find a cure for cancer

Developing new drugs is becoming increasingly difficult: research and lab experiments are time consuming and expensive. By making use of data first – screening large databases in order to discover patterns - we can make ...

Alzheimer's disease & dementia

Promising Alzheimer's treatment moves toward clinical trials

A promising new natural treatment for Alzheimer's disease is moving toward clinical trials. This will be a major step forward as there is nothing on the market that slows the progression of Alzheimer's.

Oncology & Cancer

EU rules are denying children latest cancer drugs

Children with cancer are being denied new, potentially life-saving drugs, because EU rules are allowing companies to trial some drugs only in adults, leading cancer experts warn today.

page 8 from 12